Ching-Jun Liou

Title: Ching-Jun Liou: Innovator in Cancer Treatment Technologies

Introduction

Ching-Jun Liou is a prominent inventor based in Longtan, Taiwan, known for his groundbreaking work in cancer treatment technologies. With two valuable patents to his name, Liou focuses on the development of innovative radioactive materials that integrate biocompatible substances to enhance therapeutic effectiveness against various types of cancer.

Latest Patents

Liou's latest patents include a significant innovation in using chitosan, a biocompatible compound, for cancer treatment. The patent titled "Radioactive Material Containing Chitosan for Inhibiting Cancer and Preparation Method Thereof" reveals a method of creating a radioactive material by using a chelating agent, SOCTA, to bond chitosan with radionuclides such as Re and Tc-99m. This inventive approach allows for the injection of the radioactive material containing chitosan directly into tumors, where it remains for an extended period to deliver effective therapy.

Additionally, he holds a patent for a "Radioactive Mixture and Manufacturing Method Thereof." This innovation involves the creation of a Re-MN/Lipiodol mixture through a chelating reaction, designed to treat liver cancers and other solid tumors. By utilizing Lipiodol's property of remaining in liver tumors for an extended duration, this method aims to minimize the injuries associated with surgical procedures. Furthermore, this mixture can be combined with anticancer drugs and nanoparticles to form multifunctional therapeutic modalities.

Career Highlights

Ching-Jun Liou is associated with the Atomic Energy Council - Institute of Nuclear Energy Research, where he applies his expertise to advance nuclear medicine and cancer research. His innovative contributions have not only furthered scientific understanding but have also opened new avenues for effective cancer treatments.

Collaborations

Throughout his career, Liou has collaborated with esteemed colleagues, including Tsai-Yueh Luo and notable inventor I-Chung Tang. This teamwork fosters an environment of creativity and innovation, allowing for the generation of cutting-edge solutions in the field of cancer therapy.

Conclusion

Ching-Jun Liou's dedication to harnessing nuclear technology for cancer treatment signifies a significant advancement in medical science. His innovative patents underscore the potential of combining biocompatibility with radioactive materials to enhance patient care. As research progresses, Liou's contributions could profoundly impact the future of cancer treatment methodologies.